Cherry Tree Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25
Closed -$2.71K 618
2024
Q2
$2.71K Hold
25
﹤0.01% 499
2024
Q1
$3.3K Hold
25
﹤0.01% 468
2023
Q4
$3.04K Hold
25
﹤0.01% 473
2023
Q3
$2.81K Sell
25
-2
-7% -$254 ﹤0.01% 461
2023
Q2
$3.93K Buy
+27
New +$3.67K ﹤0.01% 432

Other funds holding ZBH

Cherry Tree Wealth Management's ZBH Position: Q3 2024 in Review

Cherry Tree Wealth Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 25 shares — an estimated $2.71K sold.

Cherry Tree Wealth Management first reported a position in ZBH in Q2 2023 and held it in 5 quarters. The position peaked at $3.93K in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Cherry Tree Wealth Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Cherry Tree Wealth Management sold 25 Zimmer Biomet shares in Q3 2024, an estimated $2.71K.
  • Cherry Tree Wealth Management first reported a position in Zimmer Biomet in Q2 2023 and held it in 5 quarters.
  • Cherry Tree Wealth Management's Zimmer Biomet position peaked at $3.93K in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Cherry Tree Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.